NASDAQ · Medical - Devices

AVR (AVR) Stock

$8.28 +0.00% NASDAQ: AVR Healthcare

Valuation

MetricValue
Price$8.28
Market Cap$304.61M
P/E Ratio-2.56
P/B Ratio0.87
P/S Ratio203.52
EPS (TTM)$-4.00
52-Week High$10.94
52-Week Low$2.85
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-124.40%
ROA-32.34%
ROCE-34.20%
Gross Margin-4700.00%
Operating Margin-4700.00%
Net Margin-51.49%
Debt/Equity0.01
Current Ratio0.76

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$3.0M$3.0M$3.0M$2.0M
Operating Profit$-17.0M$-31.0M$-48.0M$-78.0M$-94.0M
Net Profit$-17.0M$-31.0M$-46.0M$-76.0M$-94.0M
EPS$-0.48$-0.85$-1.28$-3.77$-4.00
Op Margin-289.2%-972.1%-1760.3%-2899.4%-4908.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$21.0M$16.0M$31.0M$81.0M$23.0M
Total Liabilities$11.0M$7.0M$12.0M$18.0M$23.0M
Cash$15.0M$9.0M$21.0M$70.0M$13.0M
Borrowings$4.0M$1.0M$2.0M$1.0M$2.0M

Latest News

Anteris Technologies Files Offering of Up to 5.39 Million Shares MT Newswires · Jul 1, 2026 TAVR Changed Valve Replacement; Anteris Says Longer-Living Patients Expose the Next Challenge PR Newswire · Jun 15, 2026 France clearance marks key milestone for Anteris' pivotal PARADIGM Trial Proactive · Jun 8, 2026 Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis MT Newswires · Jun 8, 2026 Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance GlobeNewswire · Jun 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-29.0M$-35.0M$-61.0M$-78.0M
Investing Cash Flow$-1.0M$-3.0M$-5.0M$-5.0M$-3.0M
Financing Cash Flow$-1.0M$-1.0M$-3.0M$115.0M$-1.0M
Net Cash Flow$12.0M$-6.0M$12.0M$49.0M$-58.0M
Free Cash Flow$-15.0M$-31.0M$-37.0M$-64.0M$-80.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.08
EV / EBITDA-1.05
FCF Yield-23.01%
Quick Ratio20.93
Interest Coverage-1298.93
Return 1Y148.18%
Return 3Y
Return 5Y

Ownership

Insiders Held16.47%
Institutions Held66.90%
Institutions Float Held80.09%
Institutional HolderSharesReport Date
L1 Capital Pty Ltd7,789,0002026-03-31
Nantahala Capital Management, LLC5,530,9102026-03-31
Sio Capital Management, LLC5,382,9652026-03-31
Blackrock Inc.4,889,1532026-03-31
Adar1 Capital Management, LLC 3,789,1322026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANIK $19.61 -5.43% -19.58 $262.44M 0.00%
ARAY $0.28 +0.81% -15.50 $33.90M 0.00%
ATLN $0.90 +0.00% -1.31 $73.17M 0.00%
CYBNCybin Inc. $8.28 +1.22% -1.67 $413.02M 0.00%
LNSR $5.25 -1.87% 6.53 $63.55M 0.00%

About AVR

AVR is led by CEO Wayne Geoffrey Paterson, employs 136 people, headquartered in AU, publicly traded since 2024.

AVR stock trades at $8.28 with a market capitalization of $304.61M. The stock is valued at a price-to-earnings (P/E) ratio of -2.56, price-to-book of 0.87, price-to-sales of 203.52. Over the past 52 weeks the stock has ranged between $2.85 and $10.94, and currently trades 24.3% below its 52-week high.

On profitability, AVR generates a return on equity (ROE) of -124.40%, return on capital employed of -34.20%, an operating margin of -4700.00%, a net profit margin of -51.49%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides